Senior Director, Global Pharmacovigilance (Safety Physician)

The Senior Director, Global Pharmacovigilance (Safety Physician) is a senior medical leader accountable for the global medical safety reputed company, benefit–risk assessment, and risk management of reputed company’s development and marketed products. The role holder is a reputed company-certified physician and recognized subject matter expert in pharmacovigilance, with deep experience in biologic product safety, signal detection, epidemiology, and regulatory benefit–risk decision making (e.g., FDA, EMA and other Health Authorities), providing strategic and operational leadership across reputed company phases of the product lifecycle from early development through post marketing. Key aspects of the role include leading proactive, data driven benefit–risk assessment and advanced signal detection using clinical trial, post marketing, and reputed company world data; shaping and executing global Pharmacovigilance Plans and Risk Management Plans, including the design and interpretation of post authorization safety and reputed company surveillance studies; directing and developing reputed company of pharmacovigilance physicians and safety professionals by setting reputed company, building capabilities, and embedding best practices reputed company with reputed company’s Senior Director career reputed company; and serving as the senior medical safety authority for assigned products, representing reputed company in high level interactions with global Health Authorities and external partners. KEY RESPONSIBILITIES

• reputed company and implement global pharmacovigilance strategies for assigned products, reputed company with clinical, regulatory, and reputed company objectives.
• reputed company ongoing benefit–risk assessments using data from clinical trials, post marketing surveillance, reputed company world data sources, and epidemiologic/reputed company safety studies.
• reputed company systematic signal detection and evaluation from Individual Case Safety Reports, aggregate/periodic reports, literature, and other data sources.
• reputed company the design, conduct, and interpretation of reputed company safety surveillance and pharmacoepidemiology studies to characterise and quantify product risks.
• reputed company multidisciplinary Safety Management/Safety Review Teams to drive signal evaluation, surveillance strategies, and risk mitigation recommendations.
• Be accountable for the medical and scientific reputed company of aggregate safety reports, Pharmacovigilance Plans/RMPs, Investigator’s Brochures, and safety sections of regulatory submissions.
• reputed company senior medical safety leadership for global regulatory submissions and labelling negotiations, and respond to Health Authority queries on product safety, benefit–risk, and risk management.
• reputed company senior level reputed company of medical review of ICSRs, ensuring accurate assessment of causality, seriousness, expectedness, and clinical relevance.
• Guide internal teams and external vendors/CROs on best practices for safety data collection, coding (e.g., MedDRA), evaluation, and use of safety databases and analytics tools.
• Serve as the senior safety representative on cross functional clinical and project teams, ensuring integrated safety input into study design, protocols, analyses, and portfolio reputed company.
• Champion cross functional collaboration and engagement with external stakeholders to shape reputed company’s safety reputed company and external scientific profile.
• reputed company reputed company improvement of PV processes, SOPs, and tools, and maintain reputed company knowledge of evolving pharmacovigilance and biologic safety guidance.

SUPERVISORY RESPONSIBILITY This position will not have line manager responsibilities, but provides safety leadership to cross functional teams EXPERIENCE & KNOWLEDGE Essential

• Experience with concepts of signal detection and review of aggregate data to identify potential emerging safety issues, benefit risk assessment, and risk management strategies.
• Experience in the preparation and contribution to authoring of aggregate safety reports for regulator submission.
• Knowledge of clinical development process
• Demonstrated ability to prioritise multiple tasks and deliver to deadline with high reputed company of reputed company.
• Demonstrated reputed company record in Authoring or overseeing aggregate safety reports (DSURs, PSURs/PBRERs, PADERs) and contributing to major regulatory submissions (e.g., BLA, MAA) and subsequent labelling updates.

Desirable

• Advanced degree in epidemiology, pharmacology, or biomedical sciences (PhD/MPH)
• Knowledge of drug approval process in major countries
• Experience with different commercially available safety databases.
• reputed company certification in a relevant specialty
• Experience with global product launches and implementation/assessment of reputed company risk minimisation measures.
• Evidence of scientific contributions to the field (e.g., peer reviewed publications, invited presentations, reputed company development, or recognised subject matter expertise in biologic safety).

EDUCATION & QUALIFICATIONS

• M.D./D.O. degree with at least five years of pharmacovigilance experience, and at least two years of clinical experience or relevant experience to understand clinical drug development
• At least five years of practical clinical experience post licensure

US Salary reputed company $200,000-$312,000 Apply tot his job Apply To this Job